$PHR
Phreesia, Inc. Stock $phr

$phr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000141240821000024 Filed on March 31, 2021

Income Statement

Concept	2021 Q1	2021	2020 Q4
Revenue	$41.81M	$148.7M	$38.46M
YoY Change	27.41%	19.15%	17.11%
Cost Of Revenue	$14.78M	$52.40M	$14.00M
YoY Change	32.32%	17.23%	24.0%
Gross Profit	$27.02M	$96.30M	$24.46M
YoY Change	24.86%	20.22%	13.5%
Gross Profit Margin	64.63%	64.77%	63.59%
Selling, General & Admin	$24.95M	$83.43M	$20.85M
YoY Change	44.39%	32.82%	34.25%
% of Gross Profit	92.34%	86.64%	85.25%
Research & Development	$6.360M	$22.62M	$5.732M
YoY Change	30.86%	21.47%	20.07%
% of Gross Profit	23.54%	23.49%	23.43%
Depreciation & Amortization	$4.250M	$15.91M	$2.447M
YoY Change	16.44%	14.25%	13.66%
% of Gross Profit	15.73%	16.52%	10.0%
Operating Expenses	$35.31M	$106.1M	$26.58M
YoY Change	34.16%	30.23%	30.91%
Operating Profit	-$8.290M	-$25.67M	-$6.114M
YoY Change	77.44%	67.81%	174.05%
Interest Expense	-$370.0K	$1.695M	$471.0K
YoY Change	-45.59%	-44.3%	-15.44%
% of Operating Profit
Other Income/Expense, Net	$230.0K	-$1.572M	-$405.0K
YoY Change	-182.14%	-76.8%	185.21%
Pretax Income	-$8.420M	-$27.24M	-$6.519M
YoY Change	49.56%	23.42%	174.72%
Income Tax	-$320.0K	$49.00K	$194.0K
% Of Pretax Income
Net Earnings	-$8.100M	-$27.29M	-$6.713M
YoY Change	120.83%	34.49%	175.46%
Net Earnings / Revenue	-19.37%	-18.36%	-17.45%
Basic Earnings Per Share		-$0.69	-$0.17
Diluted Earnings Per Share	-$182.0K	-$0.69	-$0.17
COMMON SHARES
Basic Shares Outstanding	44.90M shares	39.52M shares	38.51M shares
Diluted Shares Outstanding		39.52M shares	38.51M shares

Balance Sheet

Concept	2021 Q1	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$218.8M	$218.8M	$254.1M
YoY Change	142.3%	142.3%	178.01%
Cash & Equivalents	$218.8M	$218.8M	$254.1M
Short-Term Investments
Other Short-Term Assets	$2.392M	$9.000M	$8.500M
YoY Change	168.46%	30.43%	23.19%
Inventory
Prepaid Expenses	$7.254M		$6.825M
Receivables	$29.05M	$29.10M	$27.59M
Other Receivables	$15.40M	$15.40M	$12.30M
Total Short-Term Assets	$272.3M	$272.3M	$302.5M
YoY Change	106.99%	107.07%	135.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.66M	$29.30M	$19.16M
YoY Change	84.03%	102.07%	33.39%
Goodwill	$8.307M		$250.0K
YoY Change	3222.8%		-0.4%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.670M	$3.600M	$207.0K
YoY Change	827.78%	44.0%	-84.37%
Total Long-Term Assets	$54.40M	$54.40M	$35.54M
YoY Change	99.85%	99.27%	30.61%
TOTAL ASSETS
Total Short-Term Assets	$272.3M	$272.3M	$302.5M
Total Long-Term Assets	$54.40M	$54.40M	$35.54M
Total Assets	$326.7M	$326.7M	$338.1M
YoY Change	105.76%	105.73%	116.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.389M	$4.400M	$4.215M
YoY Change	-27.06%	-26.67%	-29.15%
Accrued Expenses	$18.32M	$19.40M	$12.66M
YoY Change	98.25%	110.87%	57.92%
Deferred Revenue	$10.84M
YoY Change	100.67%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.900M	$4.900M	$4.700M
YoY Change	1186.09%	113.04%
Total Short-Term Liabilities	$54.99M	$55.00M	$41.78M
YoY Change	55.55%	55.37%	30.19%
LONG-TERM LIABILITIES
Long-Term Debt	$6.500M	$6.500M	$24.40M
YoY Change	-66.57%	-69.77%	26.07%
Other Long-Term Liabilities	$1.900M	$1.900M	$2.200M
YoY Change
Total Long-Term Liabilities	$8.400M	$8.400M	$26.60M
YoY Change	-56.8%	-60.93%	37.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.99M	$55.00M	$41.78M
Total Long-Term Liabilities	$8.400M	$8.400M	$26.60M
Total Liabilities	$63.36M	$63.40M	$68.37M
YoY Change	11.37%	11.42%	28.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$311.8M		-$303.7M
YoY Change	9.59%		8.14%
Common Stock	$449.0K		$440.0K
YoY Change	22.68%		22.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.965M		$869.0K
YoY Change	1144.36%
Treasury Stock Shares	99.52K shares
Shareholders Equity	$263.3M	$263.3M	$269.7M
YoY Change
Total Liabilities & Shareholders Equity	$326.7M	$326.7M	$338.1M
YoY Change	105.76%	105.73%	116.83%

Cashflow Statement

Concept	2021 Q1	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$8.100M	-$27.29M	-$6.713M
YoY Change	120.83%	34.49%	175.46%
Depreciation, Depletion And Amortization	$4.250M	$15.91M	$2.447M
YoY Change	16.44%	14.25%	13.66%
Cash From Operating Activities	$4.080M	$2.890M	-$670.0K
YoY Change	218.75%	249.88%	-77.89%
INVESTING ACTIVITIES
Capital Expenditures	-$7.480M	$11.24M	-$3.700M
YoY Change	136.71%	60.24%	4.82%
Acquisitions		$6.510M
YoY Change
Other Investing Activities	-$6.510M	-$6.510M
YoY Change
Cash From Investing Activities	-$13.99M	-$25.09M	-$3.700M
YoY Change	342.72%	103.61%	4.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$174.8M	$174.8M
YoY Change		33.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-25.43M	$150.7M	174.3M
YoY Change	-3201.22%	50.26%	-8360.19%
NET CHANGE
Cash From Operating Activities	4.080M	$2.890M	-670.0K
Cash From Investing Activities	-13.99M	-$25.09M	-3.700M
Cash From Financing Activities	-25.43M	$150.7M	174.3M
Net Change In Cash	-35.34M	$128.5M	169.9M
YoY Change	3233.96%	44.71%	-2059.86%
FREE CASH FLOW
Cash From Operating Activities	$4.080M	$2.890M	-$670.0K
Capital Expenditures	-$7.480M	$11.24M	-$3.700M
Free Cash Flow	$11.56M	-$8.351M	$3.030M
YoY Change	160.36%	34.93%	506.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2021Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	us-gaap:Liabilities
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentNet
CY2021Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001412408
CY2021	dei	City Area Code CityAreaCode	888
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-01-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-38977
CY2021	dei	Entity Registrant Name EntityRegistrantName	PHREESIA, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2275479
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	434 Fayetteville St
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Raleigh
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27601
CY2021	dei	Local Phone Number LocalPhoneNumber	654-7473
CY2021	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value per share
CY2021	dei	Trading Symbol TradingSymbol	PHR
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Public Float EntityPublicFloat	1138758080	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44900069	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	218781000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90315000	USD
CY2021Q1	us-gaap	Settlement Assets Current SettlementAssetsCurrent	15488000	USD
CY2020Q1	us-gaap	Settlement Assets Current SettlementAssetsCurrent	12368000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29052000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21978000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1693000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1720000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7254000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5157000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	272268000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	131538000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40148000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35551000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26660000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14487000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	25476000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	19554000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10476000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	8735000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2654000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1248000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1594000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	525000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	271000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2725000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1199000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	658000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	775000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	8307000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	250000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1670000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	180000	USD
CY2021Q1	us-gaap	Assets Assets	326666000	USD
CY2020Q1	us-gaap	Assets Assets	158758000	USD
CY2021Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	15488000	USD
CY2020Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	12368000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4864000	USD
CY2020Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2324000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1087000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4389000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6017000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18324000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9243000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10838000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5401000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	54990000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	35353000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6471000	USD
CY2020Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	21540000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1899000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q1	us-gaap	Liabilities Liabilities	63360000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	56893000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44880883	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44880883	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36610763	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36610763	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	449000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	366000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	579599000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	386383000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311777000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284485000	USD
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	99520	shares
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	13078	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	4965000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	399000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	263306000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	101865000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	326666000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	158758000	USD
CY2021	us-gaap	Revenues Revenues	148677000	USD
CY2020	us-gaap	Revenues Revenues	124784000	USD
CY2019	us-gaap	Revenues Revenues	99889000	USD
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	23461000	USD
CY2020	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	16831000	USD
CY2019	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	15105000	USD
CY2021	phr	Payment Processing Expense PaymentProcessingExpense	28925000	USD
CY2020	phr	Payment Processing Expense PaymentProcessingExpense	27889000	USD
CY2019	phr	Payment Processing Expense PaymentProcessingExpense	21892000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42972000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	32357000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26367000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22622000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18623000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14349000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40460000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30458000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20076000	USD
CY2021	us-gaap	Depreciation Depreciation	9770000	USD
CY2020	us-gaap	Depreciation Depreciation	8753000	USD
CY2019	us-gaap	Depreciation Depreciation	7552000	USD
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6138000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	5171000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4042000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	174348000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	140082000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	109382000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-25671000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-15298000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-9494000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1023000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3307000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2058000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1573000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2445000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3504000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1572000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6775000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5568000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27243000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22073000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15062000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1780000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27292000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-20293000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15062000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14955000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	56175000	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	30199000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27292000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91423000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45261000	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.50
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-24.53
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39519640	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20301189	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1844929	shares
CY2018Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	176291000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-167683000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15062000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1447000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	361000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	163000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	0	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	30199000	USD
CY2019	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	30199000	USD
CY2019Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	206490000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-210974000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-20293000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6177000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1809000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	833000	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	56175000	USD
CY2020	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	56175000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	14955000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	6412000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	124370000	USD
CY2020	phr	Temporary Equity Stock Issued During Period Value Conversion On Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOnConvertibleSecurities	262665000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	262665000	USD
CY2020	phr	Cashless Exercise Of Common Stock Warrants CashlessExerciseOfCommonStockWarrants	2000	USD
CY2020	phr	Conversion And Exercise Of Warrants Value ConversionAndExerciseOfWarrantsValue	8805000	USD
CY2020	phr	Treasury Stock From Option Exercises TreasuryStockFromOptionExercises	399000	USD
CY2020Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	101865000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27292000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13489000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5300000	USD
CY2021	phr	Treasury Stock From Option Exercises TreasuryStockFromOptionExercises	4566000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	174510000	USD
CY2021	phr	Cashless Exercise Of Common Stock Warrants CashlessExerciseOfCommonStockWarrants	0	USD
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	263306000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27292000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-20293000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15062000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15908000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13924000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11594000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13489000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	6177000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1447000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3307000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2058000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	389000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	445000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	798000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1073000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	phr	Cost Of Hardware Purchased By Others CostOfHardwarePurchasedByOthers	762000	USD
CY2020	phr	Cost Of Hardware Purchased By Others CostOfHardwarePurchasedByOthers	741000	USD
CY2019	phr	Cost Of Hardware Purchased By Others CostOfHardwarePurchasedByOthers	585000	USD
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2025000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1977000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1640000	USD
CY2021	phr	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	1766000	USD
CY2020	phr	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	0	USD
CY2019	phr	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	0	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-65000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-775000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6619000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5905000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3765000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1600000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	312000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	576000	USD
CY2021	phr	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	1652000	USD
CY2020	phr	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	2097000	USD
CY2019	phr	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	2500000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3821000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2367000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6004000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3681000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2317000	USD
CY2021	phr	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-1786000	USD
CY2020	phr	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	0	USD
CY2019	phr	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	0	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5382000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1087000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1601000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2890000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	826000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2130000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6510000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1190000	USD
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7334000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5305000	USD
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5109000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11241000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7015000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4724000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25085000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12320000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11023000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	174800000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	130781000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	14955000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4385000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1809000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	361000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4965000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	290000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6217000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	195000	USD
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9876000	USD
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	14800000	USD
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	20663000	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	17676000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	7000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	20000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	21042000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1167000	USD
CY2021	phr	Proceeds From Insurance Financing Arrangement ProceedsFromInsuranceFinancingArrangement	2009000	USD
CY2020	phr	Proceeds From Insurance Financing Arrangement ProceedsFromInsuranceFinancingArrangement	0	USD
CY2019	phr	Proceeds From Insurance Financing Arrangement ProceedsFromInsuranceFinancingArrangement	0	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1898000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2470000	USD
CY2021	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1691000	USD
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
CY2019	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	300000	USD
CY2019	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	69000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	112000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	136000	USD
CY2021	phr	Payment For Accrued Final Debt Payment Fee PaymentForAccruedFinalDebtPaymentFee	225000	USD
CY2020	phr	Payment For Accrued Final Debt Payment Fee PaymentForAccruedFinalDebtPaymentFee	0	USD
CY2019	phr	Payment For Accrued Final Debt Payment Fee PaymentForAccruedFinalDebtPaymentFee		USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	150661000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100266000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4193000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	128466000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	88772000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8960000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90315000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1543000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10503000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218781000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90315000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1543000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4359000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	8885000	USD
CY2020	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	2047000	USD
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	4425000	USD
CY2021	phr	Capitalized Software Obtained Through Financing CapitalizedSoftwareObtainedThroughFinancing	174000	USD
CY2020	phr	Capitalized Software Obtained Through Financing CapitalizedSoftwareObtainedThroughFinancing	0	USD
CY2019	phr	Capitalized Software Obtained Through Financing CapitalizedSoftwareObtainedThroughFinancing	0	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3359000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1253000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	20257000	USD
CY2020	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	USD
CY2019	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	USD
CY2021	phr	Debt Conversion Cashless Transfer Of Lender Fees DebtConversionCashlessTransferOfLenderFees	406000	USD
CY2020	phr	Debt Conversion Cashless Transfer Of Lender Fees DebtConversionCashlessTransferOfLenderFees	0	USD
CY2019	phr	Debt Conversion Cashless Transfer Of Lender Fees DebtConversionCashlessTransferOfLenderFees	0	USD
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	344000	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	833000	USD
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2021	phr	Receivables For Cash In Transit On Stock Option Exercise ReceivablesForCashInTransitOnStockOptionExercise	915000	USD
CY2020	phr	Receivables For Cash In Transit On Stock Option Exercise ReceivablesForCashInTransitOnStockOptionExercise	0	USD
CY2019	phr	Receivables For Cash In Transit On Stock Option Exercise ReceivablesForCashInTransitOnStockOptionExercise	0	USD
CY2021	phr	Cashless Exercise Of Common Stock Warrants Supplemental Cash Flow Information CashlessExerciseOfCommonStockWarrantsSupplementalCashFlowInformation	3060000	USD
CY2020	phr	Cashless Exercise Of Common Stock Warrants Supplemental Cash Flow Information CashlessExerciseOfCommonStockWarrantsSupplementalCashFlowInformation	3530000	USD
CY2019	phr	Cashless Exercise Of Common Stock Warrants Supplemental Cash Flow Information CashlessExerciseOfCommonStockWarrantsSupplementalCashFlowInformation	0	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	162000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1465000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2310000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	2799000	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	64000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2741000	USD
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5750000	shares
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	32.00
CY2020Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	174510000	USD
CY2021	phr	Estimated Number Of Months The Company Have Sufficient To Fund Its Operations EstimatedNumberOfMonthsTheCompanyHaveSufficientToFundItsOperations	P12M
CY2021	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) and regulations of the Securities and Exchange Commission (SEC) regarding annual financial reporting and include the accounts of Phreesia, Inc; its branch operation in Canada and its subsidiary QueueDr Inc. (collectively, the Company).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal year</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on January 31. References to fiscal 2021, 2020 and 2019, refer to the fiscal years ended January 31, 2021, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c) Reclassifications</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior period presentation to conform to the current period presentation. On the Company's balance sheet as of January 31, 2020, the Company has reclassified $2.3 million from the current portion of finance lease liabilities to the current portion of debt and finance lease liabilities, and the Company has reclassified $2.1 million from long-term finance leases to long-term debt and finance leases.</span></div>
CY2021	us-gaap	Fiscal Period FiscalPeriod	Fiscal yearThe Company’s fiscal year ends on January 31. References to fiscal 2021, 2020 and 2019, refer to the fiscal years ended January 31, 2021, 2020 and 2019, respectively.
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain reclassifications have been made to the prior period presentation to conform to the current period presentation. On the Company's balance sheet as of January 31, 2020, the Company has reclassified $2.3 million from the current portion of finance lease liabilities to the current portion of debt and finance lease liabilities, and the Company has reclassified $2.1 million from long-term finance leases to long-term debt and finance leases.
CY2019	us-gaap	Advertising Expense AdvertisingExpense	134000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant assumptions and estimates relate to the allowance for doubtful accounts, capitalized internal-use software, the determination of the useful lives of property and equipment, the fair value of securities underlying stock-based compensation, the fair value of identifiable assets and liabilities in a business acquisition, and the realization of deferred tax assets.
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant assumptions and estimates relate to the allowance for doubtful accounts, capitalized internal-use software, the determination of the useful lives of property and equipment, the fair value of securities underlying stock-based compensation, the fair value of identifiable assets and liabilities in a business acquisition, and the realization of deferred tax assets.
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of credit risk<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM3OGQ4MjQzMzg3ZTQ1ZmU4NmIzNjIzNWQzMjBkMjJmL3NlYzpjNzhkODI0MzM4N2U0NWZlODZiMzYyMzVkMzIwZDIyZl8xMTUvZnJhZzozODQwNGJlN2M0YmQ0YWU1OTQ3Njc3OWNmZTBkNzNmMi90ZXh0cmVnaW9uOjM4NDA0YmU3YzRiZDRhZTU5NDc2Nzc5Y2ZlMGQ3M2YyXzM4NDgyOTA3MzQxMTg_0da66d4f-681f-4e97-8163-95c448bb4f33">one</span> or <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM3OGQ4MjQzMzg3ZTQ1ZmU4NmIzNjIzNWQzMjBkMjJmL3NlYzpjNzhkODI0MzM4N2U0NWZlODZiMzYyMzVkMzIwZDIyZl8xMTUvZnJhZzozODQwNGJlN2M0YmQ0YWU1OTQ3Njc3OWNmZTBkNzNmMi90ZXh0cmVnaW9uOjM4NDA0YmU3YzRiZDRhZTU5NDc2Nzc5Y2ZlMGQ3M2YyXzM4NDgyOTA3MzQxMjU_6a6ceaa3-daf9-48d1-947c-39c1eb7464f4">two</span> business days to settle which mitigates the associated risk of concentration. The Company has one third-party payment processor.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s customers are primarily physician’s offices located in the United States and pharmaceutical companies. The Company did not have any individual customers that represented more than 10% of total revenues for the years ended January 31, 2021 and January 31, 2020. As of January 31, 2021, the Company had receivables from an entity that accounted for 10% of total accounts receivable.</span></div>Risks and uncertainties<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the COVID-19 Pandemic</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the ongoing outbreak of a novel strain of coronavirus (COVID-19) a pandemic and the United States declared a national emergency with respect to COVID-19. </span><span style="color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There continues to be uncertainty as to the extent to which the global COVID-19 pandemic may adversely impact our business operations, financial performance, and results of operations at this time. </span></div><div style="margin-top:6pt"><span style="color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Risks and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a variety of risk factors, including the economy, data privacy and security laws, government regulations, and other risks associated with the markets in which we operate including reliance on third party vendors, partners, and service providers. As with any business, operation of the Company involves risk, including the risk of service interruption impacting the operations of our business and our customer’s facilities below expected levels of operation, shut downs due to the breakdown or failure of information technology and communications systems, changes in laws or regulations, or catastrophic events such as fires, earthquakes, floods, explosions, global health concerns such as pandemics or other similar occurrences affecting the delivery of our productions and services. The occurrence of any of these events could significantly reduce or eliminate revenues generated, or significantly increase the expenses of our operations, adversely impacting the Company’s operating results and our ability to meet our obligations and commitments. See Note 6 - Debt and Finance Lease Liabilities, for a summary of our contractual commitments as of January 31, 2021.</span></div>
CY2021	phr	Number Of Third Party Payment Processors NumberOfThirdPartyPaymentProcessors	1	processors
CY2021	us-gaap	Advertising Expense AdvertisingExpense	558000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	251000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	943000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5750000	shares
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	32.00
CY2020Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	174800000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8946000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5033000	USD
CY2021Q1	phr	Accrued Processing Fee AccruedProcessingFee	2853000	USD
CY2020Q1	phr	Accrued Processing Fee AccruedProcessingFee	2738000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6525000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1472000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18324000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9243000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66808000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50038000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40148000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35551000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26660000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14487000	USD
CY2021	us-gaap	Depreciation Depreciation	9770000	USD
CY2020	us-gaap	Depreciation Depreciation	8753000	USD
CY2019	us-gaap	Depreciation Depreciation	7552000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	19933000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	12283000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	10389000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	7724000	USD
CY2021	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	7663000	USD
CY2020	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5852000	USD
CY2019	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5109000	USD
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	5884000	USD
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4933000	USD
CY2019	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4009000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10476000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	8735000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3250000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1470000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	525000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	271000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2725000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1199000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	254000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	238000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	33000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	508000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	508000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	494000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	410000	USD
CY2021Q1	phr	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	805000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2725000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	250000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	250000	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8057000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	8307000	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	29751000	USD
CY2020Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	22921000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	943000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29052000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21978000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	943000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	454000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	698000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2021Q1	phr	Prepaid Software And Business Systems PrepaidSoftwareAndBusinessSystems	2322000	USD
CY2020Q1	phr	Prepaid Software And Business Systems PrepaidSoftwareAndBusinessSystems	1611000	USD
CY2021Q1	phr	Prepaid Computer Equipment PrepaidComputerEquipment	18000	USD
CY2020Q1	phr	Prepaid Computer Equipment PrepaidComputerEquipment	645000	USD
CY2021Q1	phr	Prepaid Data Center Expenses PrepaidDataCenterExpenses	1211000	USD
CY2020Q1	phr	Prepaid Data Center Expenses PrepaidDataCenterExpenses	751000	USD
CY2021Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1311000	USD
CY2020Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1259000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2392000	USD
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	891000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7254000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5157000	USD
CY2021	phr	Hosting Arrangement Service Contract Implementation Cost Capitalized Additions HostingArrangementServiceContractImplementationCostCapitalizedAdditions	893000	USD
CY2021Q1	us-gaap	Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization	23000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2021	phr	Other Miscellaneous Income Expense OtherMiscellaneousIncomeExpense	61000	USD
CY2021	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-60000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1023000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1073000	USD
CY2020	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	49000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	676000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	636000	USD
CY2021	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	676000	USD
CY2020	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	631000	USD
CY2021	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	1287000	USD
CY2020	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	671000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1287000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	676000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5401000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6488000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5097000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5252000	USD
CY2021	phr	Contract With Customer Liability Current Period Revenue Recognized ContractWithCustomerLiabilityCurrentPeriodRevenueRecognized	1512000	USD
CY2020	phr	Contract With Customer Liability Current Period Revenue Recognized ContractWithCustomerLiabilityCurrentPeriodRevenueRecognized	7485000	USD
CY2021	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	55000	USD
CY2020	us-gaap	Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination	0	USD
CY2021	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	11991000	USD
CY2020	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	11650000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10838000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5401000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P3Y
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2025000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1977000	USD
CY2019	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2020	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3314000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3194000	USD
CY2021	phr	Capitalized Contract Cost Increase From Contract Acquisitions CapitalizedContractCostIncreaseFromContractAcquisitions	1652000	USD
CY2020	phr	Capitalized Contract Cost Increase From Contract Acquisitions CapitalizedContractCostIncreaseFromContractAcquisitions	2097000	USD
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2025000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1977000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2941000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3314000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1693000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1720000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1248000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1594000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2941000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3314000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2020Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20000000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9702000	USD
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3612000	USD
CY2021Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	1533000	USD
CY2020Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	808000	USD
CY2021Q1	phr	Long Term Debt Accrued Interest And Payments LongTermDebtAccruedInterestAndPayments	100000	USD
CY2020Q1	phr	Long Term Debt Accrued Interest And Payments LongTermDebtAccruedInterestAndPayments	381000	USD
CY2021Q1	phr	Long Term Debt And Lease Obligations Gross Including Original Issue Discount LongTermDebtAndLeaseObligationsGrossIncludingOriginalIssueDiscount	11335000	USD
CY2020Q1	phr	Long Term Debt And Lease Obligations Gross Including Original Issue Discount LongTermDebtAndLeaseObligationsGrossIncludingOriginalIssueDiscount	24801000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2020Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	937000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	11335000	USD
CY2020Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	23864000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4864000	USD
CY2020Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	2324000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6471000	USD
CY2020Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	21540000	USD
CY2021Q1	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	4965000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9702000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1145000	USD
CY2021Q1	phr	Finance Lease Liability Payments Due Year One Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearOneDiscountedObligation	3820000	USD
CY2021Q1	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	3629000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	439000	USD
CY2021Q1	phr	Finance Lease Liability Payments Due Year Two Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearTwoDiscountedObligation	3190000	USD
CY2021Q1	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	2284000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	49000	USD
CY2021Q1	phr	Finance Lease Liability Payments Due Year Three Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearThreeDiscountedObligation	2235000	USD
CY2021Q1	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	302000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q1	phr	Finance Lease Liability Payments Due Year Four Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearFourDiscountedObligation	302000	USD
CY2021Q1	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	155000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2021Q1	phr	Finance Lease Liability Payments Due Year Five Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearFiveDiscountedObligation	155000	USD
CY2021Q1	phr	Long Term Debt And Lease Obligations Gross Including Original Issue Discount LongTermDebtAndLeaseObligationsGrossIncludingOriginalIssueDiscount	11335000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1633000	USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021	us-gaap	Interest Expense InterestExpense	1695000	USD
CY2020	us-gaap	Interest Expense InterestExpense	3043000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3510000	USD
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	122000	USD
CY2020	us-gaap	Interest Income Operating InterestIncomeOperating	598000	USD
CY2019	us-gaap	Interest Income Operating InterestIncomeOperating	6000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1573000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2445000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3504000	USD
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	290000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5750000	shares
CY2020Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	32.00
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	174800000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5055505	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.45
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1230382	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.78
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	691371	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	78064	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.20
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5516452	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.80
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y2M19D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	150152000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3824259	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.41
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M28D
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	109351000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	978170	shares
CY2020	phr	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	5.31
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5516452	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2216368	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.39
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	88730	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.45
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3211354	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.67
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y11M26D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	194676000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2315820	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.62
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M18D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	142824000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	709435	shares
CY2021	phr	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	6.31
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	33575000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13960000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1355000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3972000	USD
CY2021	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-60000	USD
CY2020	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	49000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2654000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1087000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1899000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2986000	USD
CY2021Q1	phr	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	19933000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	10389000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9544000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3820000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5882000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9702000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.035
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M12D
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.044
CY2021	phr	Operating Lease Cost Excluding Variable Lease Cost OperatingLeaseCostExcludingVariableLeaseCost	1766000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	257000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2023000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2876000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	326000	USD
CY2021	phr	Finance Lease Cost FinanceLeaseCost	3202000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1171000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4142000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1142000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	3356000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	760000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2294000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	52000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	316000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	158000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3125000	USD
CY2021Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10266000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	139000	USD
CY2021Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	564000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2986000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9702000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1824000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	819000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	464000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	277000	USD
CY2020Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3384000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1629000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	326000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000	USD
CY2021	phr	Lease Payments LeasePayments	4585000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4359000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	8885000	USD
CY2021	phr	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	13244000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2741000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1629000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1780000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.08
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	114000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-1005000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-116000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-65000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	116000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-775000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1780000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.10
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.44
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.07
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.08
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.04
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.04
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.71
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.08
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	51973000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33641000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1162000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1340000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	2823000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	329000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	443000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	251000	USD
CY2021Q1	phr	Deferred Tax Assets Disallowed Interest Expense DeferredTaxAssetsDisallowedInterestExpense	1586000	USD
CY2020Q1	phr	Deferred Tax Assets Disallowed Interest Expense DeferredTaxAssetsDisallowedInterestExpense	1358000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2020Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	106000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	57987000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37025000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54563000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35369000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3424000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1656000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1568000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	440000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	758000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Deferred Expense Other Capitalized Costs DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts	881000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2766000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	881000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	658000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	775000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54563000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35369000	USD
CY2021Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27292000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-20293000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-15062000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14955000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	56175000	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	30199000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27292000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91423000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45261000	USD
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39519640	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20301189	shares
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1844929	shares
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.50
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-24.53
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5406004	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7039007	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31205249	shares
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD

Files In Submission

Name	View Source	Status
0001412408-21-000024-index-headers.html	Edgar Link	pending
0001412408-21-000024-index.html	Edgar Link	pending
0001412408-21-000024.txt	Edgar Link	pending
0001412408-21-000024-xbrl.zip	Edgar Link	pending
ex32-phrsecondamendedandre.htm	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phr-20210131.htm	Edgar Link	pending
phr-20210131.xsd	Edgar Link	pending
phr-20210131_cal.xml	Edgar Link	unprocessable
phr-20210131_def.xml	Edgar Link	unprocessable
phr-20210131_g1.jpg	Edgar Link	pending
phr-20210131_g2.jpg	Edgar Link	pending
phr-20210131_g3.jpg	Edgar Link	pending
phr-20210131_htm.xml	Edgar Link	completed
phr-20210131_lab.xml	Edgar Link	unprocessable
phr-20210131_pre.xml	Edgar Link	unprocessable
phr-fy2021xex231x10xkconse.htm	Edgar Link	pending
phr-fy2021xex311x10xkxceo3.htm	Edgar Link	pending
phr-fy2021xex312x10xkxcfo3.htm	Edgar Link	pending
phr-fy2021xex321x10xkxceo1.htm	Edgar Link	pending
phr-fy2021xex322x10xkcfo13.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHR
Phreesia, Inc. Stock $phr

2021 Q1 Form 10-K Financial Statement

#000141240821000024 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHR Phreesia, Inc. Stock $phr

2021 Q1 Form 10-K Financial Statement

#000141240821000024 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHR
Phreesia, Inc. Stock $phr